Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • x Allergen immunotherapy (5)
  • AllergoOncology (2)
  • Allergy diagnosis (28)
  • Allied health and primary care (2)
  • Anaphylaxis (13)
  • Artificial Intelligence (2)
  • Asthma (16)
  • Basic immunology (3)
  • Biologicals (5)
  • Biomarkers (3)
  • COVID19 (2)
  • Dermatology (20)
  • Drug allergy (13)
  • ENT (4)
  • Environmental allergy and climate change (1)
  • Eosinophilic esophagitis (1)
  • Epidemiology (4)
  • Food allergy (18)
  • Genomics and proteomics (1)
  • Immune deficiencies and autoimmunity (7)
  • Immunomodulation and nutrition (1)
  • Infections (5)
  • Insect venom hypersensitivities (4)
  • Mastocytosis and mast cells (1)
  • Microbiome (1)
  • Occupational allergy (2)
  • One Health (1)
  • Pediatrics (13)
  • Prevention (2)
Poster available until
Poster categories
  • x e-Thematic Poster Session (5)
  • Thematic Poster Session (76)
keywords
Session Reference
5 results
Thumbnail

000248 - Evaluation of the tolerability of the administration of subcutaneous immunotherapy in a cluster schedule, in patients with rhinoconjunctivitis and/or asthma with sensitization to Olea europaea with or without sensitization to grasses

Thumbnail

100057 - Specific IgE molecular sensitization pattern of House dust mite allergen-components by Component Resolved Diagnosis [CRD] in 318 patients of allergic diseases [Respiratory allergy [168], Food allergy [80], Atopic dermatitis [70]

Thumbnail

100629 - Asthma outcomes in young adults completed sublingual immunotherapy in adolescence

Thumbnail

100631 - Long-term post treatment benefits of house dust mites sublingual immunotherapy in polysensitized children

Thumbnail

D1.162 - Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM